Early Trastuzumab Interruption and Recurrence-Free Survival in ERBB2-Positive Breast Cancer

Robert S. Copeland-Halperin; Mohammed Al-Sadawi; Sujata Patil; Jennifer E. Liu; Richard M. Steingart; Chau T. Dang; Anthony F. Yu

doi:10.1001/jamaoncol.2020.4749

Early Trastuzumab Interruption and Recurrence-Free Survival in ERBB2-Positive Breast Cancer

Robert S. Copeland-Halperin
, Mohammed Al-Sadawi
, Sujata Patil
, Jennifer E. Liu
, Richard M. Steingart
, Chau T. Dang
, Anthony F. Yu

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1971-1972
Number of pages	2
Journal	JAMA Oncology
Volume	6
Issue number	12
DOIs	https://doi.org/10.1001/jamaoncol.2020.4749
State	Published - Dec 2020
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Publisher link

10.1001/jamaoncol.2020.4749

Find It

Find It at U of M Libraries

Cite this

@article{3af944fa1cd44143b0265848ae56a334,

title = "Early Trastuzumab Interruption and Recurrence-Free Survival in ERBB2-Positive Breast Cancer",

author = "Copeland-Halperin, \{Robert S.\} and Mohammed Al-Sadawi and Sujata Patil and Liu, \{Jennifer E.\} and Steingart, \{Richard M.\} and Dang, \{Chau T.\} and Yu, \{Anthony F.\}",

year = "2020",

month = dec,

doi = "10.1001/jamaoncol.2020.4749",

language = "English (US)",

volume = "6",

pages = "1971--1972",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "12",

}

TY - JOUR

T1 - Early Trastuzumab Interruption and Recurrence-Free Survival in ERBB2-Positive Breast Cancer

AU - Copeland-Halperin, Robert S.

AU - Al-Sadawi, Mohammed

AU - Patil, Sujata

AU - Liu, Jennifer E.

AU - Steingart, Richard M.

AU - Dang, Chau T.

AU - Yu, Anthony F.

PY - 2020/12

Y1 - 2020/12

UR - https://www.scopus.com/pages/publications/85093968157

UR - https://www.scopus.com/pages/publications/85093968157#tab=citedBy

U2 - 10.1001/jamaoncol.2020.4749

DO - 10.1001/jamaoncol.2020.4749

M3 - Letter

C2 - 33057570

AN - SCOPUS:85093968157

SN - 2374-2437

VL - 6

SP - 1971

EP - 1972

JO - JAMA Oncology

JF - JAMA Oncology

IS - 12

ER -

Early Trastuzumab Interruption and Recurrence-Free Survival in ERBB2-Positive Breast Cancer

UN SDGs

Publisher link

Find It

Other files and links

Cite this